Literature DB >> 5846592

Addiction Research Center Inventory (ARCI): development of a general drug estimation scale.

C A Haertzen.   

Abstract

Mesh：

Year:  1965        PMID： 5846592     DOI： 10.1097/00005053-196509000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  10 in total

Review 1.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 2.  Functional biomarkers for the acute effects of alcohol on the central nervous system in healthy volunteers.

Authors:  Remco W M Zoethout; Wilson L Delgado; Annelies E Ippel; Albert Dahan; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

3.  MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.

Authors:  K P C Kuypers; N Samyn; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2006-07-08       Impact factor: 4.530

4.  Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.

Authors:  Thomas F Newton; Malcolm S Reid; Richard De La Garza; James J Mahoney; Antonio Abad; Rany Condos; Joseph Palamar; Perry N Halkitis; Jurji Mojisak; Ann Anderson; Shou-Hua Li; Ahmed Elkashef
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-29       Impact factor: 5.176

5.  Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.

Authors:  A J Hiltunen; P Lafolie; J Martel; E C Ottosson; L O Boreus; O Beck; S Borg; P Hjemdahl
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

Authors:  Deepak Cyril D'Souza; Gabriel Braley; Rebecca Blaise; Michael Vendetti; Stephen Oliver; Brian Pittman; Mohini Ranganathan; Savita Bhakta; Zoran Zimolo; Thomas Cooper; Edward Perry
Journal:  Psychopharmacology (Berl)       Date:  2008-01-29       Impact factor: 4.530

7.  Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.

Authors:  Deepak Cyril D'Souza; Mohini Ranganathan; Gabriel Braley; Ralitza Gueorguieva; Zoran Zimolo; Thomas Cooper; Edward Perry; John Krystal
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

Review 8.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

9.  Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.

Authors:  Esther Papaseit; Magí Farré; Clara Pérez-Mañá; Marta Torrens; Mireia Ventura; Mitona Pujadas; Rafael de la Torre; Débora González
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

10.  A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor.

Authors:  Lawrence P Carter; Jack E Henningfield; Y Grace Wang; Yuan Lu; Debra Kelsh; Bradley Vince; Edward Sellers
Journal:  J Psychopharmacol       Date:  2018-10-01       Impact factor: 4.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.